Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry

Apr 9

Written By Kristofer Prepelica, PhD

Kristofer Prepelica, PhD

PCCTC Trial Is First to Use Standard Ra-223 Doses, Contemporary Pain Endpoints and PRO Collection Tools

The PCCTC Germline Genetics Working Group Publishes New Guidelines